Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2024 4
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Implantable cardioverter-defibrillators in ischaemic versus non-ischaemic heart failure: Insights from the VICTORIA trial.
Gouda P, Alemayehu W, Voors AA, Lam CSP, Ezekowitz J, Pieske B, Butler J, Westerhout CM, Yogasundaram H, Sandhu RK, Armstrong PW;  on behalf of the VICTORIA Study Group. Gouda P, et al. Eur J Heart Fail. 2025 Sep;27(9):1633-1643. doi: 10.1002/ejhf.3731. Epub 2025 Jun 20. Eur J Heart Fail. 2025. PMID: 40539883 Free PMC article. Clinical Trial.
DORA: 48-week weight and metabolic changes in Black women with HIV, in a phase IIIb switch study from dolutegravir- or efavirenz- to doravirine-based first-line antiretroviral therapy.
Woods J, Sokhela S, Akpomiemie G, Bosch B, Möller K, Bhaskar E, Kruger C, Manentsa N, Tom N, Macholo P, Chandiwana N, Hill A, Moorhouse M, Venter WDF. Woods J, et al. HIV Med. 2025 Jan;26(1):81-96. doi: 10.1111/hiv.13711. Epub 2024 Sep 17. HIV Med. 2025. PMID: 39286902 Free PMC article. Clinical Trial.
Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trial.
Mentz RJ, Butler J, McMullan CJ, Wojdyla DM, Anstrom KJ, Barash I, Bonaca MP, Borentain M, Corda S, Ezekowitz JA, Gates D, Lam CSP, Lewis EF, Lindenfeld J, O'Connor CM, Ponikowski P, Reddy YNV, Rosano GMC, Saldarriaga C, Senni M, Teixeira PP, Udelson J, Urbinati A, Vlajnic V, Voors AA, Xing A, Zannad F; VICTOR Study Group. Mentz RJ, et al. Eur J Heart Fail. 2025 Sep 29. doi: 10.1002/ejhf.70033. Online ahead of print. Eur J Heart Fail. 2025. PMID: 41020754
Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care - The countrywide cross-sectional AUSTRO-PROFIT study.
Sourij H, Azhar K, Aziz F, Kojzar H, Sourij C, Fasching P, Clodi M, Ludvik B, Mader JK, Resl M, Rega-Kaun G, Ress C, Stechemesser L, Stingl H, Tripolt NJ, Wascher T, Kaser S. Sourij H, et al. Diabetes Obes Metab. 2025 Jan;27(1):111-122. doi: 10.1111/dom.15988. Epub 2024 Oct 3. Diabetes Obes Metab. 2025. PMID: 39359208 Free PMC article.